Hypertrophic Cardiomyopathy: A Contemporary and Treatable Genetic Disease: Diagnosis, Heart Failure Management, and Prevention of Sudden Death
HCM Summit VI offers attendees an opportunity to learn the clinical, morphologic, and genetic spectrum of hypertrophic cardiomyopathy (HCM) from a renowned international faculty. We will explore a detailed contemporary view of HCM in which improved diagnostic techniques and management strategies have reduced disease mortality and vastly improved thousands of patients’ lives.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Tufts University School of Medicine (TUSM) Office of Continuing Education (OCE) and the Hypertrophic Cardiomyopathy Institute at Tufts Medical Center. TUSM is accredited by the ACCME to provide continuing medical education for physicians. TUSM designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits™. Tufts University School of Medicine Office of Continuing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA. This activity provides 21.25 Contact Hours for nurses.